Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2025-09-24

Clinical Trial Update: Lorazepam and the Risk of Serious Adverse Events

View source ↗

Summary

Clinical trial update notes a risk of serious adverse events with lorazepam in participants with chronic kidney disease, based on the completed NCT07179978 stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lorazepam (Lorazepam)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Chronic Kidney Disease (CKD) | Status: COMPLETED